Which US companies depend most on US federal money?
Among 251 US-listed companies with computable shares, LOCKHEED MARTIN CORPORATION shows the highest government dependency of the companies with at least $1B in revenue: In fiscal year 2025, US federal contract obligations equal at least 83.6% of LOCKHEED MARTIN CORPORATION's reported revenue - $62.7B in federal awards against $75.0B in revenue as filed with the SEC.
Cite as: FACTANKER, https://factanker.com/government-dependency
Each company links to its own page with the full time series and the evidence tree: revenue facts (SEC filings), award records (USAspending) and identity links.
Companies with at least $1B in revenue
| Company | Share | Federal obligations | Revenue | Latest FY |
|---|---|---|---|---|
| LOCKHEED MARTIN CORPORATION | ≥ 83.6% | $62.7B | $75.0B | FY 2025 |
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | 37.5% | $2.7B | $7.3B | FY 2026 |
| CORECIVIC, INC. | ≥ 26.8% | $591.7M | $2.2B | FY 2025 |
| AEROVIRONMENT, INC | 25.5% | $504.8M | $2.0B | FY 2026 |
| THE BOEING COMPANY | ≥ 24.8% | $22.2B | $89.5B | FY 2025 |
| L3HARRIS TECHNOLOGIES, INC. | ≥ 9.6% | $2.1B | $21.3B | FY 2025 |
| RTX CORPORATION | ≥ 8.2% | $7.3B | $88.6B | FY 2025 |
| TETRA TECH INC | ≥ 8.1% | $440.1M | $5.4B | FY 2025 |
| PALANTIR TECHNOLOGIES INC. | ≥ 6.2% | $276.0M | $4.5B | FY 2025 |
| OCEANEERING INTERNATIONAL INC | ≥ 4.7% | $123.9M | $2.6B | FY 2025 |
| HONEYWELL INTERNATIONAL INC. | ≥ 4.0% | $1.5B | $37.4B | FY 2025 |
| MCKESSON CORPORATION | 2.7% | $11.1B | $403.4B | FY 2026 |
| Manhattan Associates, Inc. | ≥ 2.6% | $28.2M | $1.1B | FY 2025 |
| W.W. GRAINGER, INC. | ≥ 2.0% | $358.5M | $17.9B | FY 2025 |
| MOTOROLA SOLUTIONS INC | ≥ 1.7% | $193.7M | $11.7B | FY 2025 |
| TERADYNE, INC | ≥ 1.6% | $51.1M | $3.2B | FY 2025 |
| SENECA FOODS CORP | ≥ 1.2% | $18.6M | $1.6B | FY 2025 |
| Gartner, Inc. | ≥ 0.9% | $61.2M | $6.5B | FY 2025 |
| AIR PRODUCTS AND CHEMICALS, INC. | ≥ 0.9% | $106.7M | $12.0B | FY 2025 |
| ILLUMINA, INC. | ≥ 0.8% | $33.9M | $4.3B | FY 2025 |
| STEELCASE INC. | ≥ 0.7% | $23.3M | $3.2B | FY 2025 |
| AGILENT TECHNOLOGIES, INC. | ≥ 0.6% | $42.8M | $6.9B | FY 2025 |
| CATERPILLAR INC | ≥ 0.6% | $420.7M | $67.6B | FY 2025 |
| CUMMINS INC | ≥ 0.6% | $191.9M | $33.7B | FY 2025 |
| TUTOR PERINI CORPORATION | ≥ 0.5% | $29.8M | $5.5B | FY 2025 |
| TYSON FOODS, INC. | ≥ 0.4% | $227.0M | $54.4B | FY 2025 |
| PARKER-HANNIFIN CORPORATION | 0.4% | $81.6M | $21.5B | FY 2026 |
| ANDERSONS INC | ≥ 0.3% | $36.4M | $11.0B | FY 2025 |
| CACI International Inc | 0.3% | $30.2M | $9.6B | FY 2026 |
| COLUMBUS MCKINNON CORP | 0.3% | $3.7M | $1.2B | FY 2026 |
| KEYSIGHT TECHNOLOGIES INC | ≥ 0.3% | $15.4M | $5.4B | FY 2025 |
| Ford Motor Co | ≥ 0.2% | $474.0M | $187.3B | FY 2025 |
| FTI CONSULTING, INC. | ≥ 0.2% | $8.7M | $3.8B | FY 2025 |
| EQUINIX, INC. | ≥ 0.2% | $21.2M | $9.2B | FY 2025 |
| INTUITIVE SURGICAL, INC. | ≥ 0.2% | $21.9M | $10.1B | FY 2025 |
| PPG INDUSTRIES INC | ≥ 0.2% | $31.2M | $15.9B | FY 2025 |
| HEWLETT PACKARD ENTERPRISE COMPANY | ≥ 0.2% | $65.6M | $34.3B | FY 2025 |
| BIO-RAD LABORATORIES, INC. | ≥ 0.1% | $4.0M | $2.6B | FY 2025 |
| HOLOGIC INC | ≥ 0.1% | $6.1M | $4.1B | FY 2025 |
| ROCKWELL AUTOMATION, INC. | ≥ 0.1% | $11.9M | $8.3B | FY 2025 |
| MICROSOFT CORPORATION | 0.1% | $369.1M | $331.8B | FY 2026 |
| COMMUNITY HEALTH SYSTEMS, INC. | ≥ 0.1% | $12.2M | $12.5B | FY 2025 |
| ENERGIZER HOLDINGS, INC. | ≥ 0.1% | $2.8M | $3.0B | FY 2025 |
| GLOBUS MEDICAL INC | ≥ 0.1% | $2.3M | $2.9B | FY 2025 |
| FACTSET RESEARCH SYSTEMS INC. | ≥ 0.1% | $1.8M | $2.3B | FY 2025 |
| MORNING STAR INC | ≥ 0.1% | $1.9M | $2.4B | FY 2025 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | ≥ 0.1% | $2.0M | $3.0B | FY 2025 |
| FLOWSERVE CORP | ≥ 0.1% | $3.0M | $4.7B | FY 2025 |
| CADENCE DESIGN SYSTEMS INC | ≥ 0.1% | $2.6M | $5.3B | FY 2025 |
| CLOUDFLARE, INC. | ≥ 0.1% | $986.3k | $2.2B | FY 2025 |
| Sinclair, Inc. | ≥ 0.0% | $1.2M | $3.2B | FY 2025 |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | 0.0% | $2.0M | $5.0B | FY 2026 |
| REPUBLIC SERVICES, INC. | ≥ 0.0% | $6.2M | $16.6B | FY 2025 |
| MillerKnoll, Inc. | 0.0% | $1.6M | $3.8B | FY 2026 |
| ILLINOIS TOOL WORKS INC. | ≥ 0.0% | $4.7M | $16.0B | FY 2025 |
| DXP ENTERPRISES INC | ≥ 0.0% | $646.1k | $2.0B | FY 2025 |
| Delta Air Lines, Inc. | ≥ 0.0% | $19.0M | $63.4B | FY 2025 |
| Haemonetics Corporation | 0.0% | $372.6k | $1.3B | FY 2026 |
| MDU RESOURCES GROUP, INC. | ≥ 0.0% | $316.3k | $1.9B | FY 2025 |
| BRISTOL-MYERS SQUIBB COMPANY | ≥ 0.0% | $7.6M | $48.2B | FY 2025 |
| COHERENT CORP | ≥ 0.0% | $948.7k | $5.8B | FY 2025 |
| CISCO SYSTEMS, INC. | ≥ 0.0% | $9.7M | $56.7B | FY 2025 |
| OUTFRONT MEDIA INC. | ≥ 0.0% | $327.1k | $1.8B | FY 2025 |
| BENCHMARK ELECTRONICS, INC | ≥ 0.0% | $606.5k | $2.7B | FY 2025 |
| APTARGROUP, INC. | ≥ 0.0% | $650.0k | $3.8B | FY 2025 |
| S&P GLOBAL INC. | ≥ 0.0% | $3.6M | $15.3B | FY 2025 |
| FEDERAL SIGNAL CORPORATION | ≥ 0.0% | $341.2k | $2.2B | FY 2025 |
| AMERICAN ELECTRIC POWER COMPANY, INC. | ≥ 0.0% | $5.1M | $21.7B | FY 2025 |
| THE SHERWIN-WILLIAMS COMPANY | ≥ 0.0% | $3.4M | $23.6B | FY 2025 |
| SERVICENOW, INC. | ≥ 0.0% | $749.1k | $13.3B | FY 2025 |
| PENUMBRA, INC. | ≥ 0.0% | $200.0k | $1.4B | FY 2025 |
| DARLING INGREDIENTS INC. | 0.0% | $352.0k | $6.1B | FY 2026 |
| BECTON, DICKINSON AND COMPANY | ≥ 0.0% | $1.4M | $21.8B | FY 2025 |
| LINCOLN ELECTRIC HOLDINGS INC | ≥ 0.0% | $315.9k | $4.2B | FY 2025 |
| INTERFACE, INC. | ≥ 0.0% | $146.8k | $1.4B | FY 2025 |
| TD SYNNEX CORPORATION | ≥ 0.0% | $6.6M | $62.5B | FY 2025 |
| TRIMBLE INC. | 0.0% | $505.9k | $3.6B | FY 2026 |
| ESSENTIAL UTILITIES, INC. | ≥ 0.0% | $495.8k | $5.1B | FY 2025 |
| CONTINENTAL RESOURCES, INC. | ≥ 0.0% | $380.2k | $7.0B | FY 2025 |
| SYNOPSYS INC | ≥ 0.0% | $983.9k | $7.1B | FY 2025 |
| FIDELITY NATIONAL INFORMATION SERVICES, INC. | ≥ 0.0% | $1.4M | $10.7B | FY 2025 |
| CAL-MAINE FOODS, INC. | 0.0% | $275.7k | $2.9B | FY 2026 |
| CONAGRA BRANDS, INC. | 0.0% | $864.4k | $11.3B | FY 2026 |
| ARROW ELECTRONICS, INC. | ≥ 0.0% | $1.3M | $30.9B | FY 2025 |
| WASTE MANAGEMENT INC | ≥ 0.0% | $-33.2k | $25.2B | FY 2025 |
| INSIGHT ENTERPRISES, INC. | ≥ 0.0% | $335.3k | $8.2B | FY 2025 |
| AMPHENOL CORPORATION | ≥ 0.0% | $36.0k | $23.1B | FY 2025 |
| NEUROCRINE BIOSCIENCES INC | ≥ 0.0% | $0 | $2.9B | FY 2025 |
| ABBOTT LABORATORIES | ≥ 0.0% | $255.9k | $44.3B | FY 2025 |
| RINGCENTRAL, INC. | ≥ 0.0% | $34.4k | $2.5B | FY 2025 |
| CARDINAL HEALTH, INC. | 0.0% | $4.5M | $254.2B | FY 2026 |
| THE GOODYEAR TIRE & RUBBER COMPANY | ≥ 0.0% | $0 | $18.3B | FY 2025 |
| PARSONS CORPORATION | ≥ 0.0% | $9.6k | $6.4B | FY 2025 |
| PATTERSON COMPANIES, INC. | ≥ 0.0% | $312.5k | $6.6B | FY 2024 |
| AVERY DENNISON CORPORATION | ≥ 0.0% | $15.5k | $8.9B | FY 2025 |
| MARTIN MARIETTA MATERIALS INC | ≥ 0.0% | $62.2k | $6.2B | FY 2025 |
| SAREPTA THERAPEUTICS, INC. | ≥ 0.0% | $0 | $1.9B | FY 2025 |
| ALNYLAM PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $3.7B | FY 2025 |
| TEXTRON INC. | 0.0% | $0 | $14.8B | FY 2026 |
| Leidos Holdings, Inc. | ≥ 0.0% | $-16.9k | $16.6B | FY 2025 |
| CASELLA WASTE SYSTEMS, INC. | ≥ 0.0% | $25.3k | $1.8B | FY 2025 |
| VULCAN MATERIALS COMPANY | ≥ 0.0% | $0 | $7.9B | FY 2025 |
| Dominion Energy, Inc. | ≥ 0.0% | $-212.8k | $16.5B | FY 2025 |
| Frontier Communications Parent, Inc. | ≥ 0.0% | $5.8k | $5.9B | FY 2024 |
| NRG Energy Inc | ≥ 0.0% | $140.5k | $30.3B | FY 2025 |
| DENTSPLY SIRONA INC. | ≥ 0.0% | $88.5k | $3.7B | FY 2025 |
| UNITED PARCEL SERVICE INC | ≥ 0.0% | $940.6k | $88.7B | FY 2025 |
| INTERNATIONAL PAPER COMPANY | ≥ 0.0% | $0 | $23.6B | FY 2025 |
| Powell Industries, Inc. | ≥ 0.0% | $50.3k | $1.1B | FY 2025 |
| DXC TECHNOLOGY COMPANY | 0.0% | $0 | $12.6B | FY 2026 |
| EXELIXIS, INC. | 0.0% | $0 | $2.3B | FY 2026 |
| A. O. SMITH CORPORATION | ≥ 0.0% | $0 | $3.8B | FY 2025 |
| BIOMARIN PHARMACEUTICAL INC | ≥ 0.0% | $0 | $3.2B | FY 2025 |
| SOUTHWEST AIRLINES CO. | ≥ 0.0% | $703.2k | $28.1B | FY 2025 |
| EQUIFAX INC. | ≥ 0.0% | $186.9k | $6.1B | FY 2025 |
| PTC THERAPEUTICS, INC. | ≥ 0.0% | $0 | $1.7B | FY 2025 |
| Duolingo, Inc. | ≥ 0.0% | $6.8k | $1.0B | FY 2025 |
| MARSH & MCLENNAN COMPANIES, INC. | ≥ 0.0% | $23.7k | $27.0B | FY 2025 |
| Zoom Communications, Inc. | 0.0% | $-1.5k | $4.9B | FY 2026 |
| REVVITY, INC | ≥ 0.0% | $0 | $2.9B | FY 2025 |
| INCYTE CORPORATION | ≥ 0.0% | $0 | $5.1B | FY 2025 |
| NVIDIA CORP | ≥ 0.0% | $5.0M | $130.5B | FY 2025 |
| META PLATFORMS, INC | ≥ 0.0% | $7.4k | $201.0B | FY 2025 |
| CBRE GROUP, INC | ≥ 0.0% | $-161 | $35.2B | FY 2024 |
| ADVANCED DRAINAGE SYSTEMS, INC. | ≥ 0.0% | $81.6k | $2.9B | FY 2025 |
| WATERS CORPORATION | ≥ 0.0% | $-6.6k | $3.2B | FY 2025 |
| ARTHUR J. GALLAGHER & CO. | ≥ 0.0% | $582.0k | $13.9B | FY 2025 |
| SCANSOURCE INC | 0.0% | $0 | $3.2B | FY 2026 |
| UBER TECHNOLOGIES, INC. | ≥ 0.0% | $127.5k | $52.0B | FY 2025 |
| TYLER TECHNOLOGIES, INC. | ≥ 0.0% | $10.1k | $2.3B | FY 2025 |
| LUMEN TECHNOLOGIES, INC. | ≥ 0.0% | $39.3k | $11.3B | FY 2025 |
| Cintas Corporation | 0.0% | $83.4k | $11.3B | FY 2026 |
| WESCO International, Inc. | ≥ 0.0% | $12.2k | $23.5B | FY 2025 |
| THE NEW YORK TIMES COMPANY | ≥ 0.0% | $-23.7k | $2.8B | FY 2025 |
| GILEAD SCIENCES, INC. | ≥ -0.0% | $-9.5M | $29.4B | FY 2025 |
| HENRY SCHEIN, INC. | ≥ -0.2% | $-29.5M | $13.2B | FY 2025 |
| VSE CORPORATION | ≥ -0.5% | $-6.0M | $1.1B | FY 2025 |
| REGENERON PHARMACEUTICALS, INC. | ≥ -2.3% | $-331.7M | $14.3B | FY 2025 |
| Novavax, Inc. | ≥ -6.3% | $-71.2M | $1.1B | FY 2025 |
Smaller companies (below $1B revenue; shares above 100% mean federal awards exceed reported revenue)
| Company | Share | Federal obligations | Revenue | Latest FY |
|---|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | ≥ 374.0% | $1.5M | $400.0k | FY 2025 |
| ENSYSCE BIOSCIENCES, INC. | ≥ 104.4% | $5.3M | $5.1M | FY 2025 |
| MARKER THERAPEUTICS, INC. | ≥ 99.9% | $3.5M | $3.5M | FY 2025 |
| Sintx Technologies, Inc. | ≥ 73.2% | $745.4k | $1.0M | FY 2025 |
| APPLIED ENERGETICS, INC | ≥ 43.3% | $200.0k | $461.7k | FY 2025 |
| TEL-INSTRUMENT ELECTRONICS CORP | ≥ 33.6% | $3.1M | $9.3M | FY 2025 |
| UNITED STATES ANTIMONY CORPORATION | ≥ 25.3% | $9.9M | $39.3M | FY 2025 |
| PERSONALIS, INC. | ≥ 19.9% | $13.8M | $69.6M | FY 2025 |
| RANK ONE COMPUTING CORPORATION | ≥ 19.3% | $3.3M | $17.0M | FY 2025 |
| QUANTUM COMPUTING INC. | ≥ 14.0% | $95.7k | $682.0k | FY 2025 |
| EBR SYSTEMS, INC | ≥ 11.7% | $189.9k | $1.6M | FY 2025 |
| TELOS CORPORATION | ≥ 10.5% | $17.3M | $164.8M | FY 2025 |
| Titan Environmental Solutions Inc. | ≥ 8.0% | $767.8k | $9.6M | FY 2024 |
| GSI TECHNOLOGY, INC. | 7.9% | $2.0M | $25.1M | FY 2026 |
| BNB PLUS CORP. | ≥ 6.8% | $145.1k | $2.1M | FY 2025 |
| INTERLINK ELECTRONICS, INC | ≥ 6.8% | $806.3k | $11.9M | FY 2025 |
| Opus Genetics, Inc. | ≥ 5.9% | $836.9k | $14.2M | FY 2025 |
| LOGICMARK, INC. | ≥ 5.5% | $633.8k | $11.4M | FY 2025 |
| AMERIGUARD SECURITY SERVICES, INC. | ≥ 4.1% | $963.7k | $23.5M | FY 2025 |
| QUANTUM SI INCORPORATED | ≥ 3.8% | $92.1k | $2.4M | FY 2025 |
| Taylor Devices, Inc. | 3.2% | $1.3M | $41.6M | FY 2026 |
| CLEARTRONIC, INC. | ≥ 2.9% | $118.0k | $4.1M | FY 2025 |
| PERMA FIX ENVIRONMENTAL SERVICES INC | ≥ 2.3% | $1.4M | $61.7M | FY 2025 |
| NEUROPACE INC | ≥ 2.1% | $2.1M | $100.0M | FY 2025 |
| HARVARD BIOSCIENCE, INC. | ≥ 1.8% | $1.6M | $86.5M | FY 2025 |
| APPIAN CORPORATION | ≥ 1.7% | $12.4M | $726.9M | FY 2025 |
| METROPOLITAN LIFE INSURANCE CO | ≥ 1.6% | $14.8M | $903.0M | FY 2025 |
| MERCURY SYSTEMS INC | 1.6% | $15.7M | $983.6M | FY 2026 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | ≥ 1.3% | $2.0M | $160.0M | FY 2025 |
| Standard BioTools Inc. | ≥ 1.2% | $1.0M | $85.3M | FY 2025 |
| PCS EDVENTURES!, INC. | ≥ 1.2% | $89.6k | $7.4M | FY 2025 |
| KVH INDUSTRIES INC | ≥ 1.1% | $1.2M | $111.0M | FY 2025 |
| SOLITRON DEVICES INC | 0.9% | $154.0k | $17.0M | FY 2026 |
| MAXCYTE, INC. | ≥ 0.5% | $104.9k | $21.0M | FY 2025 |
| NEURAXIS, INC. | ≥ 0.5% | $18.0k | $3.6M | FY 2025 |
| Rapid Micro Biosystems, Inc. | ≥ 0.4% | $148.1k | $33.6M | FY 2025 |
| COURSERA, INC. | ≥ 0.4% | $3.3M | $757.5M | FY 2025 |
| SOUNDTHINKING, INC. | ≥ 0.4% | $361.0k | $104.1M | FY 2025 |
| BIODESIX, INC. | ≥ 0.3% | $300.2k | $88.5M | FY 2025 |
| IRIDEX CORP | 0.3% | $173.8k | $52.7M | FY 2026 |
| AKOYA BIOSCIENCES, INC | ≥ 0.3% | $226.4k | $81.7M | FY 2024 |
| Treace Medical Concepts, Inc. | ≥ 0.2% | $503.6k | $212.7M | FY 2025 |
| ACCELERATE DIAGNOSTICS, INC. | ≥ 0.2% | $24.8k | $11.7M | FY 2024 |
| EXPONENT INC | 0.2% | $1.2M | $582.0M | FY 2026 |
| SUNPOWER, INC | ≥ 0.2% | $604.7k | $300.0M | FY 2025 |
| QUANTERIX CORPORATION | ≥ 0.1% | $210.3k | $138.9M | FY 2025 |
| ARTIVION, INC. | ≥ 0.1% | $681.4k | $441.3M | FY 2025 |
| STAAR SURGICAL CO | 0.1% | $331.3k | $239.4M | FY 2026 |
| AVANOS MEDICAL, INC. | ≥ 0.1% | $873.6k | $701.2M | FY 2025 |
| TAT TECHNOLOGIES LTD. | ≥ 0.1% | $193.0k | $178.0M | FY 2025 |
| XOMETRY, INC. | ≥ 0.1% | $619.1k | $686.6M | FY 2025 |
| MIRUM PHARMACEUTICALS, INC. | ≥ 0.1% | $458.5k | $521.3M | FY 2025 |
| 908 DEVICES INC. | ≥ 0.1% | $37.4k | $56.2M | FY 2025 |
| TRAVERE THERAPEUTICS, INC. | ≥ 0.1% | $334.9k | $490.7M | FY 2025 |
| PROTO LABS, INC. | ≥ 0.1% | $303.9k | $533.1M | FY 2025 |
| WOLFSPEED, INC. | ≥ 0.1% | $487.3k | $757.6M | FY 2025 |
| RICHARDSON ELECTRONICS, LTD. | 0.1% | $146.6k | $228.6M | FY 2026 |
| RETRACTABLE TECHNOLOGIES INC | ≥ 0.1% | $20.5k | $38.3M | FY 2025 |
| TELA Bio, Inc. | ≥ 0.0% | $34.4k | $80.3M | FY 2025 |
| The Gorman-Rupp Company | ≥ 0.0% | $186.7k | $682.4M | FY 2025 |
| FULGENT GENETICS, INC. | ≥ 0.0% | $49.4k | $322.7M | FY 2025 |
| CRA International, Inc. | 0.0% | $145.0k | $751.6M | FY 2026 |
| Neuronetics, Inc | ≥ 0.0% | $28.3k | $149.2M | FY 2025 |
| DAY ONE BIOPHARMACEUTICALS, INC. | ≥ 0.0% | $25.9k | $158.2M | FY 2025 |
| Doximity, Inc. | 0.0% | $130.5k | $644.9M | FY 2026 |
| ALEXANDERS INC | ≥ 0.0% | $17.2k | $213.2M | FY 2025 |
| AMERICAN TOWER CORPORATION | ≥ 0.0% | $53.6k | $935.9M | FY 2025 |
| SHUTTERSTOCK, INC. | ≥ 0.0% | $105.5k | $989.9M | FY 2025 |
| SIDUS SPACE, INC. | ≥ 0.0% | $100 | $1.8M | FY 2025 |
| UFP Technologies, Inc. | ≥ 0.0% | $3.6k | $602.8M | FY 2025 |
| AGIOS PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $54.0M | FY 2025 |
| URBAN ONE, INC. | ≥ 0.0% | $0 | $374.4M | FY 2025 |
| ELECTROMED, INC. | 0.0% | $0 | $73.8M | FY 2026 |
| Ocean Power Technologies, Inc. | 0.0% | $0 | $700.0k | FY 2026 |
| VALUE LINE INC | 0.0% | $0 | $33.4M | FY 2026 |
| BLINK CHARGING CO. | ≥ 0.0% | $0 | $103.5M | FY 2025 |
| PHATHOM PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $175.1M | FY 2025 |
| R C M TECHNOLOGIES, INC. | 0.0% | $0 | $319.4M | FY 2026 |
| CUMBERLAND PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $44.5M | FY 2025 |
| Y-MABS THERAPEUTICS, INC | ≥ 0.0% | $0 | $87.7M | FY 2024 |
| ARCUTIS BIOTHERAPEUTICS, INC. | ≥ 0.0% | $0 | $372.1M | FY 2025 |
| MANNKIND CORPORATION | ≥ 0.0% | $0 | $349.0M | FY 2025 |
| INVIVYD, INC. | ≥ 0.0% | $0 | $53.4M | FY 2025 |
| TRANSMONTAIGNE PARTNERS LLC | ≥ 0.0% | $0 | $646.0M | FY 2025 |
| MIMEDX GROUP, INC. | ≥ 0.0% | $7.9k | $418.6M | FY 2025 |
| TARSUS PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $451.4M | FY 2025 |
| SAFE PRO GROUP INC. | ≥ 0.0% | $0 | $606.7k | FY 2025 |
| LEXICON PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $49.8M | FY 2025 |
| TG THERAPEUTICS, INC. | ≥ 0.0% | $0 | $616.3M | FY 2025 |
| EVOFEM BIOSCIENCES, INC. | ≥ 0.0% | $0 | $20.2M | FY 2025 |
| Esperion Therapeutics, Inc. | ≥ 0.0% | $0 | $403.1M | FY 2025 |
| ARDELYX, INC. | ≥ 0.0% | $20.2k | $407.3M | FY 2025 |
| LIGHTPATH TECHNOLOGIES INC | ≥ 0.0% | $0 | $37.2M | FY 2025 |
| CATALYST PHARMACEUTICALS, INC. | ≥ 0.0% | $19.0k | $589.0M | FY 2025 |
| SPRINGWORKS THERAPEUTICS, INC. | ≥ 0.0% | $0 | $172.0M | FY 2024 |
| Aquestive Therapeutics, Inc. | ≥ 0.0% | $0 | $44.5M | FY 2025 |
| CleanCore Solutions, Inc. | ≥ 0.0% | $0 | $2.1M | FY 2025 |
| Eton Pharmaceuticals, Inc. | ≥ 0.0% | $0 | $80.0M | FY 2025 |
| PARK AEROSPACE CORP. | 0.0% | $0 | $73.3M | FY 2026 |
| ZIONS BANCORPORATION, NATIONAL ASSOCIATION | ≥ 0.0% | $0 | $529.0M | FY 2025 |
| DAILY JOURNAL CORPORATION | ≥ 0.0% | $0 | $87.7M | FY 2025 |
| UNITED GUARDIAN INC | ≥ 0.0% | $0 | $10.5M | FY 2025 |
| RHYTHM PHARMACEUTICALS, INC. | ≥ 0.0% | $0 | $189.8M | FY 2025 |
| ADMA BIOLOGICS, INC. | ≥ 0.0% | $0 | $510.2M | FY 2025 |
| PUMA BIOTECHNOLOGY, INC. | ≥ 0.0% | $0 | $228.4M | FY 2025 |
| System1, Inc. | ≥ 0.0% | $0 | $266.1M | FY 2025 |
| CAREVIEW COMMUNICATIONS, INC. | ≥ 0.0% | $0 | $9.0M | FY 2025 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | ≥ -0.0% | $-32.6k | $277.0M | FY 2025 |
| INNODATA INC | ≥ -0.1% | $-150.0k | $251.7M | FY 2025 |
| 60 DEGREES PHARMACEUTICALS, INC. | ≥ -2.9% | $-29.0k | $1.0M | FY 2025 |
| BIOCRYST PHARMACEUTICALS, INC. | ≥ -3.3% | $-28.8M | $874.8M | FY 2025 |
| FUELCELL ENERGY, INC. | ≥ -4.2% | $-6.7M | $158.2M | FY 2025 |
Methodology & sources
Share = federal obligations (USAspending, consolidated across the corporate group) / revenue as filed with the SEC, most recent computable fiscal year per company. Precomputed weekly in the database - never by a model. '≥' marks floors (grant data not yet loaded).
Share = federal obligations (USAspending, consolidated across the corporate group) / revenue as filed with the SEC, most recent computable fiscal year per company. Precomputed weekly in the database - never by a model. '≥' marks floors (grant data not yet loaded).
Not claimed
- The two periods do not align exactly: revenue follows the company's fiscal year, obligations the US federal fiscal year (Oct-Sep).
- Years marked 'contracts only': grant/assistance awards are not yet loaded - the share is a floor, not the full figure.
- Fiscal years without a share: obligations base files not yet loaded; a missing value means missing load, not zero government business.
- Obligations are amounts obligated, not amounts paid out.
- The share consolidates all registrations of the corporate group via evidence-backed identity links (same_as facts).